Skip to main content

MCKESSON CORP

For the period ended Mar 31, 2025. Filed May 9, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed May 9, 2025

MCK$1,059.37-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

McKESSON CORPORATION
May 8, 2025/s/ Britt J. Vitalone
Britt J. Vitalone
Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:

/s/ Brian S. Tyler/s/ James H. Hinton
Brian S. TylerChief Executive Officer and Director(Principal Executive Officer)James H. Hinton, Director
/s/ Britt J. Vitalone/s/ Donald R. Knauss
Britt J. VitaloneExecutive Vice President and Chief Financial Officer(Principal Financial Officer)Donald R. Knauss, Director
/s/ Napoleon B. Rutledge Jr./s/ Bradley E. Lerman
Napoleon B. Rutledge Jr.Senior Vice President and Controller(Principal Accounting Officer)Bradley E. Lerman, Director
/s/ Richard H. Carmona/s/ Maria N. Martinez
Richard H. Carmona, M.D., DirectorMaria N. Martinez, Director
/s/ Dominic J. Caruso/s/ Kevin M. Ozan
Dominic J. Caruso, DirectorKevin M. Ozan, Director
/s/ W. Roy Dunbar/s/ Kathleen Wilson-Thompson
W. Roy Dunbar, DirectorKathleen Wilson-Thompson, Director
/s/ Deborah Dunsire
Deborah Dunsire, M.D., Director
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.